Venture roundup: Apic, Stelexis, Biond, Keros

Gene therapy company Apic Bio Inc. (Cambridge, Mass.) and cancer company Stelexis Therapeutics LLC (New York, N.Y.) each announced series A rounds of at least $40 million.

Other companies that announced venture rounds include Biond Biologics Ltd. (Misgav Industrial Park, Israel), which raised $17 million in a series B round, and Keros Therapeutics Inc. (Lexington, Mass.), which raised a $23 million series B round...